Does ERLOTINIB Cause Off label use? 1,190 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,190 reports of Off label use have been filed in association with ERLOTINIB (Erlotinib). This represents 5.3% of all adverse event reports for ERLOTINIB.
1,190
Reports of Off label use with ERLOTINIB
5.3%
of all ERLOTINIB reports
809
Deaths
198
Hospitalizations
How Dangerous Is Off label use From ERLOTINIB?
Of the 1,190 reports, 809 (68.0%) resulted in death, 198 (16.6%) required hospitalization, and 11 (0.9%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERLOTINIB. However, 1,190 reports have been filed with the FAERS database.
What Other Side Effects Does ERLOTINIB Cause?
Death (5,000)
Rash (4,648)
Diarrhoea (3,448)
Fatigue (1,548)
Nausea (1,366)
Drug ineffective (1,207)
Decreased appetite (998)
Malignant neoplasm progression (954)
Dry skin (953)
Disease progression (910)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ERLOTINIB Alternatives Have Lower Off label use Risk?
ERLOTINIB vs ERTAPENEM
ERLOTINIB vs ERTUGLIFLOZIN PIDOLATE
ERLOTINIB vs ERYTHROMYCIN
ERLOTINIB vs ERYTHROMYCIN ETHYLSUCCINATE
ERLOTINIB vs ERYTHROMYCIN LACTOBIONATE